Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
批准号:
10321005
负责人:
MARK W ALBERS
金额:
$43.66万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-12-21 至 2024-05-31
关键词:
2019-nCoVAgeAlgorithmsAlzheimer disease detectionAnosmiaArea Under CurveArgentineBiological AssayCOVID diagnosisCOVID-19 associated anosmiaCOVID-19 pandemicCOVID-19 patientCOVID-19 testCellular PhoneClinicClinicalComputersDataDevelopmentDiseaseElectronic Health RecordElementsEmployeeEvaluationGeneral HospitalsHealth PersonnelHealth ProfessionalHomeHospitalsIndividualInfectionInfluenzaInternationalLabelLung diseasesMarylandMassachusettsMolecularMolecular DiagnosisMonitorOdorsOlfactory dysfunctionOnline SystemsParticipantPatient Self-ReportPatientsPerformancePersonsPhenX ToolkitPhenotypePilot ProjectsPopulationPopulation HeterogeneityPredictive ValueProbabilityPrognosisQuarantineRehabilitation therapyResearchRiskRisk EstimateSARS-CoV-2 infectionSafetySchoolsSelf AdministrationSensitivity and SpecificitySignal TransductionSiteSmell PerceptionStudentsSymptomsSyndromeTabletsTaste PerceptionTestingTimeUniversitiesUpdateVirusWomanWorkalgorithm developmentbasecoronavirus diseaseexperienceinfection riskinfluenza infectioninnovationnew technologyrespiratoryscreeningsmell testsocial health determinantssoftware developmentundergraduate studentuniversity studentvector transmission
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract:
Self-report of sudden loss of smell or taste substantially increases the odds of being infected with SARS-CoV-2
(10 – 37-fold). However, self-report of smell function is an unreliable predictor of smell loss. Based on our
experience developing smell tests with personalized algorithms for asymptomatic detection of Alzheimer's
disease, we created a self-administered easy to use “at home” 5-minute objective smell test to uncover
alterations in smell function unbeknownst to many individuals, and confer increased risk of infection by SARS-
CoV-2. Our new smell test consists of a physical smell card containing peel and sniff odor labels and a web-
based application. The disposable smell card reduces the risk that the smell test serves as a vector of
transmission to other patients, research staff, and to health care workers. Each participant accesses the web-
based app on their own smartphone, tablet, or computer. In our pilot studies, we validated each participant's
COVID status by extracting results of clinical SARS-CoV-2 RT PCR assays from electronic health records. The
smell test provides better area under the curve for SARS-CoV-2 infection (0.83 – 0.85) in both US and
Argentinian symptomatic patients (ages 19 - 87) than symptom tracking alone (0.66). We are expanding the
smell test from one smell card with three odors to 6 smell cards, each with 3 different odors (18 odors total).
Having six different versions of the smell card will afford longitudinal screening several times per week and
provide data to construct personalized thresholds for changes in olfactory function - each person serving as
their own control and monitoring for diminishment of their expected performance based on their personal
trajectory rather than being based on population norms. Here we propose to develop a native app to conduct
longitudinal COVID Smell Test (Aim 1), collect data on asymptomatic health care workers, symptomatic
patients, and undergraduates (Aim 2) and develop algorithms for the longitudinal smell test for personalized
thresholds, differentiate smell loss from COVID relative to influenza, and assess risk of developing pulmonary
disease in COVID infected patients (Aim 3). The Longitudinal COVID Smell Test is accessible, affordable, and
readily scalable. Effective screening with the COVID smell test will better inform students and employees if
they should not report to school or work, and seek an evaluation by a healthcare professional and molecular
testing at an early, often asymptomatic, stage of the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards Universal Chemosensory Testing
-
批准号:10683613
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2023
-
负责人:MARK W ALBERS
-
依托单位:
Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD
-
批准号:10502780
-
项目类别:
-
资助金额:$248.18万
-
财政年份:2022
-
负责人:MARK W ALBERS
-
依托单位:
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
-
批准号:10439178
-
项目类别:
-
资助金额:$87.73万
-
财政年份:2020
-
负责人:MARK W ALBERS
-
依托单位:
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
-
批准号:9974450
-
项目类别:
-
资助金额:$75.93万
-
财政年份:2018
-
负责人:MARK W ALBERS
-
依托单位:
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
-
批准号:9789798
-
项目类别:
-
资助金额:$76.85万
-
财政年份:2018
-
负责人:MARK W ALBERS
-
依托单位:
Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias
-
批准号:10744875
-
项目类别:
-
资助金额:$105.47万
-
财政年份:2018
-
负责人:MARK W ALBERS
-
依托单位:
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
-
批准号:10452499
-
项目类别:
-
资助金额:$73.31万
-
财政年份:2018
-
负责人:MARK W ALBERS
-
依托单位:
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
-
批准号:10212939
-
项目类别:
-
资助金额:$74.81万
-
财政年份:2018
-
负责人:MARK W ALBERS
-
依托单位:
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimer's Disease
-
批准号:9565013
-
项目类别:
-
资助金额:$83.54万
-
财政年份:2017
-
负责人:MARK W ALBERS
-
依托单位:
Physiologic Mechanisms of Action of APP and APLP2 in Axon Targeting
-
批准号:8623239
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2013
-
负责人:MARK W ALBERS
-
依托单位:
Physiologic Mechanisms of Action of APP and APLP2 in Axon Targeting
-
批准号:8729518
-
项目类别:
-
资助金额:$20.56万
-
财政年份:2013
-
负责人:MARK W ALBERS
-
依托单位:
The Olfactory Neural Circuit as a systems Level Model of Neurodegenerative Diseas
-
批准号:7852640
-
项目类别:
-
资助金额:$265.23万
-
财政年份:2009
-
负责人:MARK W ALBERS
-
依托单位:
Mapping Molecular and Cellular Responses to Odorants
-
批准号:6634537
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2001
-
负责人:MARK W ALBERS
-
依托单位:
Mapping Molecular and Cellular Responses to Odorants
-
批准号:6321345
-
项目类别:
-
资助金额:$19.01万
-
财政年份:2001
-
负责人:MARK W ALBERS
-
依托单位:
Mapping Molecular and Cellular Responses to Odorants
-
批准号:6516284
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2001
-
负责人:MARK W ALBERS
-
依托单位:
Mapping Molecular and Cellular Responses to Odorants
-
批准号:6885372
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2001
-
负责人:MARK W ALBERS
-
依托单位:
Mapping Molecular and Cellular Responses to Odorants
-
批准号:6729127
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2001
-
负责人:MARK W ALBERS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: